Continuation Booster Trial After a Vaccine Combining Tyrosinase/GP100/MART-1 Peptides Emulsified With Montanide ISA 51 With or Without GM-CSF for Patients With Melanoma
Clinical trial NCT00184067 · TERMINATED
Trial details
- NCT number
- NCT00184067
- Sponsor
- University of Southern California
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Primary completion
- 2007-04-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.